Browse Data and Analysis

Algeria does not develop, commercialize or import genetically engineered products. The Ministry of Agriculture’s decree of December 24, 2020, prevents agricultural genetically engineered product development, commercialization as well as import into Algeria.

Egypt requires a biosafety legal framework. Without one, the country cannot move forward in the area of agricultural biotechnology. The absence of a legal framework impedes field trials, as well as the commercial use of genetically engineered (GE) crops.

As of September 2022, Israel does not have a policy restricting the use of imported genetically engineered (GE) commodities or derivative products. There are no changes in Israel’s policy towards plant, animal biotechnology, and microbial biotechnology compared to 2021.

Tunisia postponed non-urgent issues throughout 2023 as major political reforms, including a freeze on parliament and a constitutional referendum took precedent. As a result, Tunisia’s biosafety framework, which was drafted in 2014, remains on hold with no timeframe for a review and parliamentary vote.

Morocco continues to import agricultural products derived from genetically engineered (GE) technologies for use in animal feed products. No GE products have been developed or commercialized for local production in Morocco. GE products are not allowed for human consumption.

The Kingdom of Saudi Arabia’s (KSA) regulations allow the importation of biotech plant products, but they are required to be labeled if they contain more than one percent genetically engineered (GE) plant ingredients. As a result, many retail packed food importers do not import biotech foods due to concerns that biotech labeling could jeopardize their product image. However, Saudi Arabia imports large quantities of biotech U.S. corn, soybeans, and their products.